Publication at Second Faculty of Medicine |
2016
Abstract
Improper use of antibiotics is the main cause of global growth in antimicrobial resistance. The loss of effectiveness of basic and reserve antibiotics is associated with increasing medical problems, higher mortality, and high treatment costs.
New antibiotics are therefore urgently needed. Drugs that are currently registered or whose registration is being prepared enrich and enhance the possibilities in management of infections caused by multiresistant strains.
It should be emphasized, however, that they are only a temporary solution. The main task is to reduce global consumption and promote the principles of proper antibiotic policy.